Medpace Holdings (FRA:01P) Current Accrued Expense : €196 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Current Accrued Expense?

Medpace Holdings's Current Accrued Expense for the quarter that ended in Mar. 2024 was €196 Mil.

Medpace Holdings's quarterly Current Accrued Expense increased from Sep. 2023 (€183 Mil) to Dec. 2023 (€199 Mil) but then declined from Dec. 2023 (€199 Mil) to Mar. 2024 (€196 Mil).

Medpace Holdings's annual Current Accrued Expense increased from Dec. 2021 (€90 Mil) to Dec. 2022 (€131 Mil) and increased from Dec. 2022 (€131 Mil) to Dec. 2023 (€199 Mil).

Medpace Holdings Current Accrued Expense Historical Data

The historical data trend for Medpace Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Current Accrued Expense Chart

Medpace Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

67.62

77.40

89.77

131.15

199.12

Medpace Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															140.66	161.14	182.97	199.12	196.06

Medpace Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Medpace Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings (FRA:01P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

MEDP:USA MEDP:Mexico 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Medpace Holdings (FRA:01P) Headlines

No Headlines